KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $0.46.

  • Boston Scientific's EPS (Basic) rose 2105.26% to $0.46 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.97, marking a year-over-year increase of 5634.92%. This contributed to the annual value of $1.96 for FY2025, which is 5555.56% up from last year.
  • As of Q4 2025, Boston Scientific's EPS (Basic) stood at $0.46, which was up 2105.26% from $0.51 recorded in Q3 2025.
  • In the past 5 years, Boston Scientific's EPS (Basic) ranged from a high of $0.54 in Q2 2025 and a low of $0.05 during Q4 2021
  • Moreover, its 5-year median value for EPS (Basic) was $0.26 (2021), whereas its average is $0.27.
  • Per our database at Business Quant, Boston Scientific's EPS (Basic) surged by 220000.0% in 2021 and then plummeted by 6956.52% in 2022.
  • Boston Scientific's EPS (Basic) (Quarter) stood at $0.05 in 2021, then skyrocketed by 80.0% to $0.09 in 2022, then surged by 277.78% to $0.34 in 2023, then rose by 11.76% to $0.38 in 2024, then rose by 21.05% to $0.46 in 2025.
  • Its EPS (Basic) stands at $0.46 for Q4 2025, versus $0.51 for Q3 2025 and $0.54 for Q2 2025.